Masaki Hiroya | Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

IS005 Vascular Smooth Muscle Cell(VSMC)-Specific Overexpression of Angiotensin type2(AT2)Receptor Causes Endothelium-dependent Vasodilation via bradykinin/NO/cGMP pathway
IS104 Cell-specific Distribution of Angiotensin II Receptor Subtypes and Receptors-mediated Biochemical Changes in Failing Human Hearts
IS040 Angiotensin Type 2 (AT2) Receptor Inhibits AT1-mediated Intracelluar Alkalosis to Enhance Kinik Production in Vascular Smooth Muscle Cells From Vascular-targeted AT2 Transgenic Mice
IS070 Angiotensin Type 2 Receptors Are Re-expressed by Cardiac Fibroblasts from Failing Myopathic Hamster Hearts and Inhibit Cell Growth and Fibrillar Collagen Metabolism
IS050 Cardiac-Specific Overexpression of Angiotensin AT2 receptor Causes Attenuated Response to AT1 receptor - Mediated Chronotropic Action
Enhancement of Ischemia-Induced Angiogenesis by eNOS Overexpression
PE-391 Novel Cell Delivery System : Microbubbles Desturuction by Ultrasound caused Angiogenesis by Transplantation of Bone Marrow Cells in Platelet Destrucion-Dependent Manner(Angiogenesis 4 (IHD) : PE67)(Poster Session (English))
OJ-266 Bone Marrow Mononuclear Cells (BM-MNC) Implantation for the Patients with Advanced Coronary Artery Disease(Angiogenesis 2 (M) : OJ31)(Oral Presentation (Japanese))
Therapeutic Angiogenesis for Patients with Limb Ischemia by Autologous Transplantation of Bone Marrow Cells : Randomized Controlled Trial
Angiogenesis for Critical Limb Ischemia Using Autologous Bone Marrow Cell Transplantation
PJ-119 Effect of Anti-platelet Drugs at Angiogenic Cell Therapy(Peripheral circulation-8 (H) PJ20,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
Anti-platelet Drugs Inhibited Angiogenesis by Bone Marrow Cell Implantation(Peripheral Circulation/Vascular Disease (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Therapeutic Angiogenesis Therapy by Autologous Bone Marrow Cell Transplantation for Critical Limb Ischemia(An Update on the Contemporary Management of Peripheral Arterial Disease, The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Angiogenesis and Angiotensin II : Differential Postnatal Angiogenic Activities Unmasked by Gene-Engineered Mouse Models of Angiotensin AT1 and AT2 Receptor Subtypes
Angiotensin II-Mediated Novel Cardiovascular Action Unmasked by Gene-Engineered Mice of AT1 and AT2 Receptors
Impact of the Angiotensin II Receptor Antagonist, Losartan, on Myocardial Fibrosis in Patients with End-Stage Renal Disease : Assessment by Ultrasonic Integrated Backscatter and Biochemical Markers
OJ-417 Tyrosine Kinase PYK2 activates eNOS and subsequently regulates Vascular Tonus and Angiogenesis, revealed by its Knock-out Mice(Endothelium/NO 5 (H) : OJ51)(Oral Presentation (Japanese))
OE-011 Mechanism for IL-1β-mediated Neovascularization Unmasked by IL-1β Knock-out Mice(Vasoactive Compound/Growth Factor/Cytokine 1 (H) : OE2)(Oral Presentation (English))
Critical Functional Role of IL-1β in Expression and Function of VEGF Revealed by Analysis of IL-1β-/-Mice
eNOS Activation and Its Vascular Functions Critically Requires the Presence of Tyrosine Kinase PYK2
Safety and Availability of Doxazosin in Treating Hypertensive Patients with Chronic Renal Failure
OE-261 The possibility of autologus platelet intramuscular infusion therapy to chronic ischemic desease.(Peripheral circulation/Vascular disease(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)

もっと見る

スポンサーリンク